Ketamine‐Induced Sclerosing Cholangitis (KISC) in a Critically Ill Patient With COVID‐19
Sally A.I. Knooihuizen, Ariel W. Aday, William M. Lee
Abstract
1Division of Digestive and Liver DiseasesUT Southwestern Medical Center at DallasDallasTX 2Parkland Health and Hospital SystemDallasTX *ADDRESS CORRESPONDENCE AND REPRINT REQUESTS TO: Sally A.I. Knooihuizen, M.D. Division of Digestive and Liver Diseases, 5959 Harry Hines Blvd. HP05.520 Dallas, TX 75390‐8887 E‐mail: [email protected] Tel.: +1‐214‐645‐0595
Topics & Concepts
Coronavirus disease 2019 (COVID-19)MedicineCritically ill2019-20 coronavirus outbreakReprintSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)General surgeryIntensive care medicineGastroenterologyInternal medicineVirologyOutbreakInfectious disease (medical specialty)PhysicsAstronomyDiseaseGallbladder and Bile Duct DisordersPancreatitis Pathology and TreatmentIgG4-Related and Inflammatory Diseases